News | January 10, 2025
Windlas Biotech’s new injectable facility receives GMP certification
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Subscribe To Our Newsletter & Stay Updated
